Most people associate generative AI (GenAI) with large language models (LLMs). While LLMs focus specifically on generating text, GenAI encompasses a wider range of content generation tasks beyond just language, including images, music and more. Broadly speaking, GenAI uses machine learning algorithms to analyze and learn from existing data sets
Tag: synthetic data
In 2024, we will witness the proliferation of synthetic data across industries. In 2023, companies experimented with foundational models, and this trend will continue. Organizations see it as an emerging force to reshape industries and change lives. However, the ethical implications can't be overlooked. Let’s explore some industries I think
Katie King has interviewed subjects from many walks of business life for her books: academics, venture capitalists, executives from high-profile brands and telecommunications companies. Among them, one that made a lasting impression was an artist: Ai-Da. King interviewed the artificial intelligence-powered humanoid robot artist for her 2022 book AI Strategy
Over the last year, generative AI has captivated the public imagination. Many of us have become newly acquainted with the concept of an approaching Singularity coined by John von Neumann or Nick Bostrom’s Paper Clip thought experiment. Fortunately, Microsoft’s office assistant, Clippy, has yet to dutifully transform our planet into
As you read this, someone you know may be in the hospital for an acute illness. Treatments for life-threatening illnesses are often based on a combination of existing protocols and staff experience. And that’s great when hospitals are running smoothly and are adequately staffed. But too often these days, hospitals
As a member of the SAS Data Ethics Practice, I was excited to collaborate with teams at the SAS Hackathon to learn more about their ideas for trustworthy AI. Artificial Intelligence has the potential to make a difference in the real world, and partnering with the hackathon teams was a
As in most other sectors, health care is changing at lightning speed. Access to data makes it possible to speed up clinical trials, develop more personalized medication, make quicker and better diagnoses, improve the quality of patient care and save lives. The pandemic has sped up digital transformation in every
A common barrier to quantitative research, especially in health and financial areas, is the inability to share sensitive data due to confidentiality and privacy. It can be difficult and time consuming to get permission to share the data, which means useful research is delayed or not even attempted. However, collaborators seeking